Detailed information for compound 1352534

Basic information

Technical information
  • TDR Targets ID: 1352534
  • Name: 2-[[2-(2-fluorophenyl)-5-methyl-1,3-oxazol-4- yl]methylsulfonyl]-1-(4-phenylpiperazin-1-yl) ethanone
  • MW: 457.518 | Formula: C23H24FN3O4S
  • H donors: 0 H acceptors: 4 LogP: 2.83 Rotable bonds: 7
    Rule of 5 violations (Lipinski): 1
  • SMILES: O=C(N1CCN(CC1)c1ccccc1)CS(=O)(=O)Cc1nc(oc1C)c1ccccc1F
  • InChi: 1S/C23H24FN3O4S/c1-17-21(25-23(31-17)19-9-5-6-10-20(19)24)15-32(29,30)16-22(28)27-13-11-26(12-14-27)18-7-3-2-4-8-18/h2-10H,11-16H2,1H3
  • InChiKey: RSVMZNVZCLPKSE-UHFFFAOYSA-N  

Network

Hover on a compound node to display the structore

Synonyms

  • 2-[[2-(2-fluorophenyl)-5-methyl-oxazol-4-yl]methylsulfonyl]-1-(4-phenylpiperazin-1-yl)ethanone
  • 2-[[2-(2-fluorophenyl)-5-methyl-4-oxazolyl]methylsulfonyl]-1-(4-phenyl-1-piperazinyl)ethanone
  • C528-1492
  • NCGC00109428-01
  • MLS000522503
  • SMR000127770

Targets

Known targets for this compound

Species Target name Source Bibliographic reference
Homo sapiens huntingtin Starlite/ChEMBL No references
Homo sapiens SMAD family member 2 Starlite/ChEMBL No references

Predicted pathogen targets for this compound

By orthology
Species Potential target Known druggable target/s Ortholog Group
Brugia malayi hypothetical protein Get druggable targets OG5_132837 All targets in OG5_132837
Loa Loa (eye worm) transcription factor SMAD2 Get druggable targets OG5_131716 All targets in OG5_131716
Onchocerca volvulus Huntingtin homolog Get druggable targets OG5_132837 All targets in OG5_132837
Loa Loa (eye worm) MH2 domain-containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Brugia malayi MH2 domain containing protein Get druggable targets OG5_131716 All targets in OG5_131716
Onchocerca volvulus Huntingtin homolog Get druggable targets OG5_132837 All targets in OG5_132837
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132837 All targets in OG5_132837
Loa Loa (eye worm) hypothetical protein Get druggable targets OG5_132837 All targets in OG5_132837

By sequence similarity to non orthologous known druggable targets
Species Potential target Known druggable target Length Alignment span Identity
Brugia malayi MH2 domain containing protein SMAD family member 2 467 aa 405 aa 31.6 %

Obtained from network model

Ranking Plot


Putative Targets List


Species Potential target Raw Global Species
Onchocerca volvulus 0.0184 0.0425 1
Loa Loa (eye worm) hypothetical protein 0.0148 0.004 0.004
Trichomonas vaginalis carboxylesterase domain containing protein, putative 0.0184 0.0425 0.5
Brugia malayi hypothetical protein 0.0184 0.0425 0.0425
Brugia malayi Carboxylesterase family protein 0.1092 1 1
Loa Loa (eye worm) hypothetical protein 0.0184 0.0425 0.0425
Loa Loa (eye worm) hypothetical protein 0.0184 0.0425 0.0425
Loa Loa (eye worm) carboxylesterase 0.0184 0.0425 0.0425
Echinococcus granulosus acetylcholinesterase 0.1092 1 1
Brugia malayi Carboxylesterase family protein 0.0184 0.0425 0.0425
Brugia malayi Carboxylesterase family protein 0.0184 0.0425 0.0425
Loa Loa (eye worm) carboxylesterase 0.0184 0.0425 0.0425
Loa Loa (eye worm) hypothetical protein 0.0184 0.0425 0.0425
Echinococcus multilocularis acetylcholinesterase 0.1092 1 1
Loa Loa (eye worm) hypothetical protein 0.0184 0.0425 0.0425
Loa Loa (eye worm) hypothetical protein 0.1092 1 1
Schistosoma mansoni family S9 non-peptidase homologue (S09 family) 0.1092 1 1
Echinococcus multilocularis acetylcholinesterase 0.1092 1 1
Echinococcus granulosus carboxylesterase 5A 0.1092 1 1
Echinococcus multilocularis carboxylesterase 5A 0.1092 1 1
Onchocerca volvulus 0.0184 0.0425 1
Mycobacterium tuberculosis Carboxylesterase LipT 0.0184 0.0425 0.5
Loa Loa (eye worm) hypothetical protein 0.0184 0.0425 0.0425
Brugia malayi Carboxylesterase family protein 0.0184 0.0425 0.0425
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0184 0.0425 0.5
Echinococcus granulosus acetylcholinesterase 0.1092 1 1
Loa Loa (eye worm) acetylcholinesterase 1 0.1092 1 1
Loa Loa (eye worm) hypothetical protein 0.0184 0.0425 0.0425
Mycobacterium ulcerans carboxylesterase, LipT 0.0184 0.0425 0.5
Onchocerca volvulus 0.0184 0.0425 1
Loa Loa (eye worm) carboxylesterase 0.1092 1 1
Loa Loa (eye worm) hypothetical protein 0.0148 0.004 0.004
Trichomonas vaginalis spcc417.12 protein, putative 0.0184 0.0425 0.5
Mycobacterium tuberculosis POSSIBLE PARA-NITROBENZYL ESTERASE (FRAGMENT) 0.0184 0.0425 0.5
Loa Loa (eye worm) hypothetical protein 0.0184 0.0425 0.0425
Loa Loa (eye worm) hypothetical protein 0.1092 1 1
Brugia malayi hypothetical protein 0.0148 0.004 0.004
Onchocerca volvulus 0.0184 0.0425 1
Brugia malayi Carboxylesterase family protein 0.0184 0.0425 0.0425
Onchocerca volvulus 0.0184 0.0425 1

Activities

Activity type Activity value Assay description Source Reference
Potency (functional) 0.0891 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) = 10 um PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] ChEMBL. No reference
Potency (functional) 21.1923 uM PubChem BioAssay. qHTS for Inhibitors of ATXN expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 22.3872 um PUBCHEM_BIOASSAY: qHTS Assay for Enhancers of SMN2 Splice Variant Expression. (Class of assay: confirmatory) ChEMBL. No reference
Potency (binding) = 22.3872 um PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) 23.1093 uM PUBCHEM_BIOASSAY: qHTS screen for small molecules that inhibit ELG1-dependent DNA repair in human embryonic kidney (HEK293T) cells expressing luciferase-tagged ELG1. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493107, AID493125] ChEMBL. No reference
Potency (functional) 25.1189 uM PubChem BioAssay. qHTS of PTHR Inhibitors: Primary Screen. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 35.4813 um PUBCHEM_BIOASSAY: qHTS Assay for Modulators of Lamin A Splicing. (Class of assay: confirmatory) ChEMBL. No reference
Potency (binding) = 35.4813 um PUBCHEM_BIOASSAY: qHTS for Inhibitors of Tau Fibril Formation, Thioflavin T Binding. (Class of assay: confirmatory) [Related pubchem assays: 596 ] ChEMBL. No reference
Potency (functional) 35.4813 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] ChEMBL. No reference
Potency (functional) 35.4813 uM PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] ChEMBL. No reference
Potency (functional) = 39.8107 um PUBCHEM_BIOASSAY: qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (without detergent). (Class of assay: confirmatory) [Related pubchem assays: 2158 (Confirmation qHTS Assay for Inhibitors of Cruzain), 2249 (Probe Development Summary of Promiscuous Inhibitors (Artifacts) of Cruzain), 2161 (qHTS Assay for Inhibitors of Papain: Counterscreen for Cruzain Assay), 1478 (qHTS Assay for Promiscuous and Specific Inhibitors of Cruzain (with detergent))] ChEMBL. No reference
Potency (functional) 50.1187 uM PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) = 79.4328 um PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of DNA Polymerase Beta. (Class of assay: confirmatory) ChEMBL. No reference
Potency (functional) 89.1251 uM PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Histone Lysine Methyltransferase G9a. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504404] ChEMBL. No reference

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
 
In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

Bibliographic References

No literature references available for this target.

If you have references for this compound, please enter them in a user comment (below) or Contact us.